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REPORT
Mutations in the Gene Encoding the Wnt-Signaling Component
R-Spondin 4 (RSPO4) Cause Autosomal Recessive Anonychia
C. Bergmann,* J. Senderek* D. Anhuf, C. T. Thiel, A. B. Ekici, P. Poblete-Gutie´rrez, M. van Steensel,
D. Seelow, G. Nu¨rnberg, H. H. Schild, P. Nu¨rnberg, A. Reis, J. Frank, and K. Zerres
Anonychia is an autosomal recessive disorder characterized by the congenital absence of ﬁnger- and toenails. In a large
German nonconsanguineous family with four affected and ﬁve unaffected siblings with isolated total congenital an-
onychia, we performed genomewide mapping and showed linkage to 20p13. Analysis of the RSPO4 gene within this
interval revealed a frameshift and a nonconservative missense mutation in exon 2 affecting the highly conserved ﬁrst
furin-like cysteine-rich domain. Both mutations were not present among controls and were shown to segregate with the
disease phenotype. RSPO4 is a member of the recently described R-spondin family of secreted proteins that play a major
role in activating the Wnt/b-catenin signaling pathway. Wnt signaling is evolutionarily conserved and plays a pivotal
role in embryonic development, growth regulation of multiple tissues, and cancer development. Our ﬁndings add to the
increasing body of evidence indicating that mesenchymal-epithelial interactions are crucial in nail development and put
anonychia on the growing list of congenital malformation syndromes caused by Wnt-signaling–pathway defects. To the
best of our knowledge, this is the ﬁrst gene known to be responsible for an isolated, nonsyndromic nail disorder.
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Anonychia (MIM 206800) is deﬁned as the absence of ﬁn-
ger- and toenails.1 Usually, anonychia and its milder phe-
notypic variant hyponychia occur as a feature of genetic
syndromes and may be associated with signiﬁcant limb
anomalies. Well-known examples are Cofﬁn-Siris syn-
drome (MIM 135900), different ectodermal dysplasias
(MIM 129490, MIM 300291, MIM 224900), nail-patella
syndrome (MIM 161200), and brachydactyly type B (MIM
113000). Most of these syndromes are transmitted in an
autosomal dominant mode. In contrast, isolated, nonsyn-
dromic anonychia without additional features is a rare
entity that may present either as a so-called partial au-
tosomal dominant form that affects only the thumbs2 or—
in its most severe, autosomal recessively inherited vari-
ant—with involvement of all digits and toes.3 So far,
no gene or locus has been reported for nonsyndromic
anonychia.
We describe a large, nonconsanguineousGerman family
with four children afﬂicted with isolated total congenital
anonychia (ﬁg. 1). Both parents and ﬁve siblings were un-
affected. Further family history was unremarkable. Af-
fected individuals were of normal height and proportion-
ate stature and were not different in any aspect, besides
anonychia, from their healthy siblings. In any affected
individual, anonychia had been present since birth.X-rays
of the right upper limb and foot of individual II-8 showed
normal results (ﬁg. 2). No additional malformations were
found on clinical examination of affected siblings, neither
of ectodermal structures nor of sensory organs. There was
no report of inner abnormalities in any affected individ-
ual, and an additional abdominal ultrasound performed
in individual II-8 showed normal results. All siblings were
of normal intelligence. The youngest affected sibling is 36
years old, the eldest currently 47 years old. All affected
individuals have healthy children with normal nails.
We obtained blood samples after receiving informed
consent from all individuals of this family (who were all
adults) and extracted genomic DNA using standard pro-
cedures. To identify the causative disease locus in this fam-
ily, we undertook a genomewide linkage scan using a
panel of microsatellite markers with an average distance
of 10 cM (Weber panel Version 10 [Research Genetics]),
an ABI3100 sequence analyzer, and Genotyper software
v3.7 (Applied Biosystems) (table 1). We achieved marker
saturation by use of existing and newly generated micro-
satellite markers. We performed two-point LOD score cal-
culations by use of the LINKAGE program package, with
help from the computer programs LINKRUN and MKS,
with an autosomal recessive, fully penetrant model. We
identiﬁed two regions with multipoint LOD scores 12, on
chromosome 10 and chromosome 20 (ﬁg. 3). The candi-
date interval on chromosome 10 comprised 27.7 Mb be-
tween the ﬂanking markers D10S1214 and D10S1221. The
candidate region on chromosome 20p could be further
reﬁned by typing additional microsatellite markers from
the draft human genome sequence to a 7.8-Mb region on
chromosome 20p13 ﬂanked by D20S1155 and the newly
established STRmarkerAL021879.At about the same time,
1106 The American Journal of Human Genetics Volume 79 December 2006 www.ajhg.org
Figure 1. Top left, Pedigree of the German nonconsanguineous family with isolated total congenital anonychia, with four affected
and ﬁve unaffected siblings. Top right and middle right, Hands and feet of affected individual II-8, showing isolated total congenital
anonychia. Middle left, Maternally transmitted guanine nucleotide insertion leading to a frameshift and premature truncation of the
corresponding protein (c.92_93insG, p.Leu31fs). Bottom left, paternal nonconservative RSPO4 missense mutation c.218GrA leading to
an amino acid exchange from cysteine to tyrosine at position 73 (p.Cys73Tyr). Bottom right, Multiple protein sequence alignment,
generated with the program ClustalW with use of translation from genome assemblies and expressed sequences. Sequence comparison
shows that the identiﬁed RSPO4 missense mutation c.218GrA (p.Cys73Tyr) affects an amino acid (displayed on a grayish background)
that is highly conserved in evolution.
Table 1. LOD Score Data for Chromosomes 10
and 20
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
consanguineous pedigrees with autosomal recessively in-
herited anonychia were reported to be linked to the same
region on chromosome 20.4
Given the multitude of genes in the chromosome 20p13
region, we aimed to further narrow the candidate interval.
Under the hypothesis of distant parental consanguinity,
we additionally performed a genomewide screening for
homozygous regions in an affected individual of the fam-
ily (individual II-7 in ﬁg. 1) by use of the 100K Affymetrix
SNP set of arrays (table 2). With a Perl script (available
from the authors on request), genotypes from the SNP
array and STR analysis were merged and sorted according
to their physical positions. Homozygous stretches of 10
adjacent SNPs in the candidate region were detected, and
all genes or ESTs contained in these homozygous seg-
ments were analyzed by direct sequencing. However, no
change was identiﬁed that cosegregated with the disease
phenotype.
Thus, we next prioritized genes within the mapped crit-
ical interval on 20p13 formutational screening, on thebasis
of putative function and expression data, using the Uni-
versity of California–Santa Cruz (UCSC) human genome
database. Initially, we designed primers (see Primer3 Web
site) for the entire coding and adjacent intronic regions of
the SOX12 (MIM 601947), TCF15 (MIM 601010), SCRT2
(GenBank accession number NM_033129), RSPO4 (Gen-
Bank accession number NM_001029871), SNPH (GenBank
accession number NM_014723), TGM3 (MIM 600238),
TGM6 (GenBank accession number NM_198994),ADRA1D
(MIM 104219), and BMP2 (MIM 112261) genes and per-
formed direct sequencing using genomic DNA of an af-
fected individual (individual II-7 in ﬁg. 1) on anABI PRISM
310 genetic analyzer (Applied Biosystems). Primer se-
quences are available on request.
No convincing change was identiﬁed in any of the other
candidates; however, we detected two mutations in exon
2 of the RSPO4 gene and conﬁrmed segregation of the
changes with the phenotype in this family. Neither mu-
tation has been described previously in public domain
databases. As shown in ﬁgure 1, the maternally transmit-
ted mutation was a guanine nucleotide insertion leading
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Figure 2. X-ray of the right hand of affected individual II-8,
showing no skeletal alteration or any degenerative or inﬂammable
joint process.
Figure 3. Genomewide linkage data generated using a panel of
microsatellite markers. The legend is available in its entirety in
the online edition of The American Journal of Human Genetics.
to a frameshift and premature truncation of the corre-
sponding protein (c.92_93insG, p.Leu31fs) (GenBank ac-
cession number NP_001025042). Sixty healthy German
controls tested by BglI restriction enzyme analysis were
negative for this change, further corroborating its path-
ogenicity. On the paternal allele, the nonconservative
missense mutation c.218GrA, which leads to an amino
acid exchange from cysteine to tyrosine at position 73
(p.Cys73Tyr), was identiﬁed. The affected residue is high-
ly conserved in evolution, was not found among 300
German white control chromosomes tested by HpyCH4III
restriction enzyme analysis and, thus, is thought to be
pathogenic too.
RSPO4 spans ∼44 kb of genomic DNA and comprises
ﬁve exons that encode a secreted protein of 234 aa.5 The
R-spondin protein family was only recently described and
comprises four independent gene products in mammals
that are widely expressed and are predicted to share a
common organization with substantial structural homol-
ogies.6 It is noteworthy that each of the ﬁve exons con-
stitutes a predicted structural domain. Although the N-
terminal signal peptide sequences (exon 1) share only
relatively weak conservation, the two adjacent cysteine-
rich furin-like domains encoded by exons 2 and 3 and the
single thrombospondin (TSP-1) motif that is encoded by
exon 4 display signiﬁcant similarity among protein family
members. Finally, the C-terminal basic region encoded by
exon 5 is of varying length and scores as a nuclear local-
ization signal.
The R-spondin proteins were recently shown to play a
major role in activating the Wnt/b-catenin signaling
pathway.5,7 Wnt signaling is known to be evolutionarily
conserved and pivotal for embryonic development by reg-
ulation of cell morphology, proliferation, and motility.5,
8,9 Its inappropriate activation has been reported in several
human cancers.10 All four human R-spondin family mem-
bers, as well as a splice variant of RSPO4 (GenBank ac-
cession number NM_001040007), were recently shown to
be able to induce proliferation of intestinal epithelium.5
The functions of R-spondins essentially overlapwith those
of the canonical Wnt ligands by binding to the Frizzled
(Fzd) family receptors (MIM 606143) and the low-density
lipoprotein–related receptor (LRP) 5 (MIM 603506) or
LRP6 coreceptor (MIM 603507), ultimately leading to gene
activation by b-catenin (MIM 116806) and the T-cell factor
(TCF)-lymphoid enhancer factor (LEF) family transcrip-
tion factor complex (MIM 153245). A minimum of 10
different Fzd-related receptors are known in the human
genome, and it might be hypothesized that a greater de-
gree of selectivity is achieved through speciﬁc responses
of cells to Wnt or R-spondin ligands that may be dictated
by the available, possibly cell-line– or tissue-speciﬁc Fzd
receptor(s) on the cell surface.11 Moreover, it has recently
been shown that mouse R-spondin proteins increase the
activity of Wnt ligands, possibly through a direct inter-
action.7 There is also evidence of independent receptor-
signaling pathways of R-spondin proteins that may inter-
sect those of Wnt only at the b-catenin level.5 This adds
to the growing body of evidence that a wide range of
soluble ligands is capable of activating the b-catenin trans-
duction complex, expanding well beyond the canonical
Wnt-Fzd system. On the other hand, as noted above, R-
spondins contain furin-like domains. Furin is a subtilisin
family serine protease that is involved in the processing
of many different proteins (MIM 136950).12 Notably, the
Dickkopf (DKK) proteins (MIM 605189), regulators of
Wnt activity, possess furin cleavage sites13; thus, it is con-
ceivable that the R-spondin family may indirectly regu-
late Wnt-pathway activity through regulation of DKK
activation.
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Table 2. Screen for Homozygous Regions in
Affected Individual II-7 for the Critical Region on
Chromosome 20, Performed Using the 100K
Affymetrix SNP Set of Arrays
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
It is noteworthy that both RSPO4 mutations detected in
our family affect the highly conserved ﬁrst furin-like cys-
teine-rich domain. Experimental data suggest that a short-
ened RSPO4 protein comprising just the two furin-like
regions is sufﬁcient for b-catenin stabilization, further sup-
porting the harmful character of the identiﬁed mutations.
Evidence of the pathogenicity of the missense change
c.218GrA (p.Cys73Tyr) is striking, particularly given that
the cysteine residues within the furin-like domains are
strictly conserved among R-spondins and in evolution (ﬁg.
1).5 RSPO4 mutation analysis in further families may an-
swer the intriguing question of whether mutations in do-
mains other than the highly conserved furin-like regions
result in a similar clinical phenotype or allow for a residual
protein function, conceivably giving rise to a milder ex-
pression pattern with hyponychia. Likewise, it may also
be hypothesized that RSPO4 mutations in other function-
ally important regions might lead to a more severe phe-
notype, with skeletal involvement and reduction defects
of distal limbs.
This hypothesis ﬁts the long-standing argument of
bone-dependent nail formation and, in particular, the ob-
servation that nail development depends on correct dorso-
ventral polarization.14 Embryonic development of the hu-
man ﬁngernails begins at the 8th or 9th wk of gestation
and ends by the 20th wk, with completion of the toenails
lagging ∼4 wk behind.15 Recent molecular data have in-
dicated a crucial role for epithelial-mesenchymal inter-
action at different developmental stages in terms of proper
nail development. These critical ﬁrst steps require expres-
sion ofWnt7a (MIM 601570),Noggin (MIM602991), Bmp4
(bone morphogenetic protein 4 [MIM 112262]), and
Lmx1b (MIM 602575), among others.16,17 Mutations in
LMX1B cause nail-patella syndrome (MIM 161200), and
it has been suggested that the LIM-domainhomeoboxpro-
tein Lmx1b is required for dorsal speciﬁcation and hence
for nail development.18 Indeed, it turns out that Wnt-7a
induces the expression of Lmx1b in the dorsal limb mes-
enchyme. In the ventral limb bud, Engrailed-1 (MIM
131290) represses Wnt-7a expression.19 Thus, it is con-
ceivable that, in the absence of RSPO4, Wnt-7a activity in
the developing limb is reduced. In that scenario, the es-
tablishment of dorsal-ventral polarity in the developing
limb would be disturbed, and the nail would ﬁnally fail
to be speciﬁed. Pertinent conﬁrmation of this idea could
be obtained, for instance, by conditional knockout ex-
periments in mice.
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